IL1B and diabetes mellitus: However, a study combining anti-CD3 treatment with either Anakinra or an anti-IL-1β antibody resulted in reversal of diabetes in recent-onset T1D NOD mice (142), suggesting that combined therapy may also improve clinical efficacy in humans.